Bilberry for Eye Fatigue / Digital Eye Strain

Verdict: Weak, conflicted evidence; not proven for eye fatigue

Bilberry has only weak, disputed support for relieving digital eye strain: a handful of small trials report modest improvements, but no high-quality independent evidence confirms it works. It is not an established treatment.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The entire human evidence base is four small, double-blind Japanese RCTs (n=20-109, 4-12 weeks), all pointing the same direction. The two best (PMID 25923485 and PMID 32106548) showed bilberry extract eased screen-induced declines in critical flicker fusion (p=0.023) and improved an objective marker of ciliary-muscle accommodation (p=0.014-0.017). But every trial was industry-funded, doses ranged five-fold with no dose-response, and two studies (PMID 34376917, PMID 22199129) bundled bilberry with lutein, astaxanthin or fish oil, so bilberry's own effect can't be isolated.

Crucially, there is no Cochrane review or large independent meta-analysis, and a 2022 ophthalmology systematic review of computer-vision-syndrome treatments found no high-quality evidence that supplements like bilberry help. That gap between consistent-but-small industry trials and absent independent confirmation is why the grade is weak and flagged as disputed.

Authorities reinforce the caution. The FDA has only issued warning letters to bilberry eye-supplement sellers for unproven disease claims; NIH/NCCIH calls it cautious, Mayo hedges, and Cleveland Clinic and Harvard Health do not address it for eye strain at all. An older 2009 WHO monograph lists ophthalmic uses, but it predates modern evidence standards. Bilberry may modestly soothe tired eyes for some, but proof of benefit is genuinely unsettled, and high doses carry antiplatelet/bleeding interactions.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.49
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
67%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.46
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.494
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Bilberry extract supplementation for preventing eye fatigue in video display terminal workers
PMID: 25923485 2015 RCT (double-blind) n = 88
Finding: VDT-induced CFF reduction was significantly alleviated in the bilberry group at week 8 (95% CI 0.10-1.60; p=0.023); subjective ocular fatigue, ocular pain, eye heaviness, uncomfortable sensation and foreign body sensation were also improved more than placebo (p<0.05).
⚠️ Industry-funded Effect size: CFF difference vs placebo: 95% CI 0.10-1.60 Hz; p=0.023
View on PubMed
A 12-Week-Long Intake of Bilberry Extract (Vaccinium myrtillus L.) Improved Objective Findings of Ciliary Muscle Contraction of the Eye: An RCT
PMID: 32106548 2020 RCT (double-blind) n = 109
Finding: Post-VDT-load HFC-1 values were significantly improved in the SBE group vs placebo at week 8 (p=0.014) and week 12 (p=0.017), indicating relief of tonic ciliary-muscle accommodation after VDT tasks.
⚠️ Industry-funded Effect size: HFC-1 between-group difference: p=0.014 (wk8), p=0.017 (wk12)
View on PubMed
Effects of anthocyanin, astaxanthin, and lutein on eye functions: a randomized, double-blind, placebo-controlled study
PMID: 34376917 2021 RCT (double-blind) n = 44
Finding: Active group showed significant improvement in percentage of pupillary (accommodative) response and in subjective scores for 'trouble focusing the eyes' and 'difficulty seeing nearby objects/fine print' versus placebo; exact p-values not reported in abstract.
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans
PMID: 22199129 2011 RCT (double-blind) n = 20
Finding: Active group showed improvement vs placebo in asthenopia-related items ('stiff shoulder/low back pain', 'frustration', 'dry-eye', 'stuffy head') and in 4-week mental-fatigue VAS score; very small sample, exact p-values not reported in abstract.
🟠 Limited quality
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
The studies [of Bilberry] reveal that blood vessels are strengthened, circulation improves, blood glucose levels may be lowered, prevention of cell damage are all benefits that Bilberry may provide. source↗
L4b EU EFSA
Neutral
L4d TW TFDA / 衛福部
Neutral
目前公告之健康食品保健功效共有13項:護肝、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。(衛福部食藥署「健康食品概說暨導覽」) source↗
L4e WHO
Supportive
Uses supported by clinical data: Oral use for the symptomatic treatment of dysmenorrhoea associated with premenstrual syndrome, circulatory disorders in patients with capillary leakage or peripheral vascular insufficiency and ophthalmic disorders. Uses described in pharmacopoeias and well established documents: Oral use for the treatment of acute diarrhoea and local irritation or inflammation o… source↗
L5a NIH Office of Dietary Supplements
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-eye-fatigue-INT-bilberry-001 繁體中文版 →